Agreed!

Who's "we" and what would that look like?

We're talking largely about private companies operating in a global market (esp. when dealing with wealthy countries). If a US buyer is willing to buy $1000 and a UK buyer says we're not paying more than $100, should the pharmaceutical company be banned from selling to the UK at that price? No one is forcing the pharmaceutical companies to sell to UK here. If they feel it's in their interest to accept the $100 then surely they should be free to do so.

I think you're mixing up different news reports. Cuba reduced their mother-child HIV transmission using five generic antiretrovirals that were invented in the USA and Canada: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688320/

I'm not sure what would be a perfectly comprehensive metric for health innovations by country. Drug patents might be sort of close[1], but maybe Cuba doesn't apply for patents on principled grounds. For Cuba, it would be helpful to know the ratio of the USA using drugs or other innovations developed in Cuba versus American ones used in Cuba. I hear that drug development can cost billions of dollars[2] so I'd be surprised if Cuba could afford it, but maybe they've done it. Anyone know of any new drugs invented in Cuba?

[1] e.g. https://www.americanactionforum.org/weekly-checkup/new-drug-...

[2] https://www.scientificamerican.com/article/cost-to-develop-n...